Provided by Tiger Trade Technology Pte. Ltd.

Summit

25.70
0.0000
Volume:- -
Turnover:7.17M
Market Cap:377.45M
PE:6.61
High:25.70
Open:25.70
Low:25.70
Close:25.70
52wk High:31.49
52wk Low:17.06
Shares:14.69M
Float Shares:12.98M
Volume Ratio:- -
T/O Rate:- -
Dividend:0.86
Dividend Rate:3.35%
EPS(TTM):3.89
EPS(LYR):3.82
ROE:14.13%
ROA:1.35%
PB:0.86
PE(LYR):6.72

Loading ...

Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Yesterday

Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit

GlobeNewswire
·
Yesterday

Summit Networks Has Cease Trade Order Revoked by BCSC

TIPRANKS
·
Feb 05

Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit

GlobeNewswire
·
Feb 05

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Feb 05

MiMedx announces distribution agreement with Summit Products Group

TIPRANKS
·
Feb 04

MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products

GlobeNewswire
·
Feb 04

UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit

GlobeNewswire
·
Feb 04

Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Feb 04

Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Feb 04

Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit

GlobeNewswire
·
Feb 04

Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026

GlobeNewswire
·
Feb 04

Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Feb 04

Summit Minerals Delays General Meeting as Keystone Acquisition Timeline Extended

TIPRANKS
·
Feb 04

X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

GlobeNewswire
·
Feb 03

Summit Midstream Names Chief Commercial Officer

MT Newswires Live
·
Feb 03

Ripple Participates in High-Stakes White House Summit

utoday
·
Feb 03

Press Release: Summit Midstream Appoints Chris Tennant as Chief Commercial Officer

Dow Jones
·
Feb 03

Summit Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 02

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

GlobeNewswire
·
Jan 30